Team - Molecular Oncology Lab
Group Leader: Alimonti Andrea, MD
After graduating in Medicine at the University of Rome “La Sapienza” and specializing in Oncology at the National Cancer Institute of Rome, he worked as a Postdoc in New York and at the Harvard Medical School in Boston. Since 2011 he is Director of the Laboratory of Molecular Oncology at the IOR. He is Full Professor of Oncology at USI, Full Professor of Pharmacology at the University of Padua and Full Professor of Experimental Oncology at ETH Zurich. During his career, he has obtained important awards and competitive Grants (Swiss Bridge Award, ERC Grants, J. Steiner Cancer Research Award, Prostate Cancer Foundation Award, Award from the Benioff Initiative for Prostate Cancer Research).
Andrea Alimonti is the author of over 100 scientific publications and his major contribu- tions include:
- Discovery of a therapeutic approach based on the induction of cellular senescence and immune response against the tumor.
- Identification of an immune cell type, the myeloid suppressor cells, that can promote prostate cancer progression and resistance to standard therapies.
- Identification of a novel mechanism of therapy resistance in prostate cancer involving the gut microbiota.
Alimonti Andrea, Group leader
Braga Daniele, Bioinformatician
Bressan Silvia, PostDoc
Brina Daniela, Research Associate
Calì Bianca, PostDoc
Colucci Manuel, PostDoc
D'Elia Nicoletta, Director's Assistant
Du Yingxi, PhD Student
Gianfanti Federico, Research Assistant
Kohl Anna, PhD Student
Lai Ping, PhD Student
Li Yingrui, PhD Student
Li Yuxin, PhD Student
Maddalena Martino, PostDoc
Maraccani Luisa, PhD Student
Moscarda Viola, Visiting Research Fellow
Naud Sabrina, PostDoc
Papin Stéphanie, PostDoc
Pasquini Emiliano, Lab Manager
Pernigoni Nicolò, PostDoc
Robesti Daniele, Visiting Research Fellow
Troiani Martina, PostDoc
Valdata Aurora, PhD Student